China Atorvastatin Market 2018

1
Investigation Report on China Atorvastatin
Market, 2009-2018byResearch In China

• Explore all reports for Life Sciences market
• _at_ http//www.chinamarketresearchreports.com/cat/li
  fe-sciences.html .

2
Investigation Report on China Atorvastatin
Market, 2009-2018

• The collection of Life Sciences market research
  reports has a new addition of Investigation
  Report on China Atorvastatin Market, 2009-2018On
  chinamarketresearchreports.com. The prevalence
  rate of abnormal blood lipid in China is lower
  than that in most developed countries, but the
  average serum TC level of Chinese people is
  upgrading for the economic development and
  lifestyle change. Meanwhile, diabetes and
  metabolic syndromes are very common in China.
• According to statistics, the prevalence rate of
  abnormal blood lipid is above 20 in the group
  aged at 18 or above. The total number of patients
  exceeds 200 million.
• Blood lipidlowering drugs performs better than
  the overall drug market and cardiovascular system
  drugs. The expanding rate of blood lipidlowering
  drugs is obviously higher than that of
  cardiovascular system drugs and the proportion in
  the cardiovascular system drug market is
  increasing.
• Inquire for discount _at_ http//www.chinamarketresea
  rchreports.com/contacts/inquiry.php?name114714 .

3
Investigation Report on China Atorvastatin
Market, 2009-2018

• Atorvastatin, marketed by Pfizer as a calcium
  salt under the trade name Lipitor, is a member of
  the drug class known as statins, used for
  lowering blood cholesterol. It works by
  inhibiting HMGCoA reductase. In November 2011,
  Pfizer lost the patent protection in the USA. In
  May 2012, Pfizer lost the patent protection in
  the U.K. either. Liptor is the most popular drug
  of Pfizer with the accumulated sales value over
  USD 100 billion. It is the first drug with sales
  value breaking USD 100 billion in the history.
• There are many enterprises producing APIs and
  finished products of atorvastatin. The market
  share of finished products is mainly occupied by
  Pfizer, which is above 80 by sales value every
  year. According to CRI's investigation, the CAGR
  of atorvastatin in China sample hospital market
  is above 40 during 20052013.
• According to clinic research, atorvastatin has
  certain curative effects on osteoporosis,
  Alzheimer's disease, heart disease, organ
  transplantation, stroke and diabetes.
• Complete report is available _at_ www.chinamarketrese
  archreports.com/114714-toc.html .

4
Investigation Report on China Atorvastatin
Market, 2009-2018

• Through this report, the readers can acquire the
  following information
• Market Share of Major Atorvastatin Manufacturers
  in sample Hospitals in China
• Sales price of atorvastatin in hospital market in
  China
• Major atorvastatin enterprises in China
• Market share of atorvastatin by dosage form in
  hospital market in China
• Prospect of China atorvastatin market
• The following enterprises and people are
  recommended to purchase this report
• Atorvastatin API and finished product
  manufacturers
• Medical Institutions
• Investors /research agencies focusing
  atorvastatin market
• Inquire for discount _at_ http//www.chinamarketresea
  rchreports.com/contacts/inquiry.php?name114714 .

5
Investigation Report on China Atorvastatin
Market, 2009-2018

• Table of Contents
• 1 Relevant Concepts of Atorvastatin1.1
  Indication1.2 Sales Status on the Global Market
• 2 Market Overview of Atorvastatin in China2.1
  Patent Status2.2 Major Manufacturers2.3 Market
  Size
• 3 Investigation on Sales Value of Atorvastatin in
  China, 2009-20133.1 Total Sales Value3.2 Sales
  Value by Region
• 4 Investigation on Market Share of Major
  Atorvastatin Manufacturers in China,
  2009-20134.1 Market Share by Sales Value4.2
  Market Share by Sales Volume
• Complete report is available _at_ www.chinamarketrese
  archreports.com/114714-toc.html .

6
Investigation Report on China Atorvastatin
Market, 2009-2018

• 5 Investigation on Market Size of Atorvastatin by
  Dosage Form in China, 2009-20135.1 Market Share
  by Sales Value and Dosage Form5.2 Market Share
  by Sales Volume and Dosage Form
• 6 Reference Price of Atorvastatin in Hospital
  Market in China, 20136.1 Price of Lipitor
  Produced by Dalian Pfizer Co., Ltd.6.2 Price of
  Atorvastatin Produced by Ireland Pfizer Co.,
  Ltd.6.3 Price of Atorvastatin Produced by Henan
  Topfond Pharmaceutical Co., Ltd.6.4 Price of
  Atorvastatin Produced by Beijing Jialin
  Pharmaceutical Co., Ltd.6.5 Price of
  Atorvastatin Produced by Pfizer Co., Ltd. (the
  U.S.A.)
• 7 Analysis on Major Atorvastatin Manufacturers in
  China, 2009-20137.1 Pfizer7.2 Beijing Jialin
  Pharmaceutical Co., Ltd.Inquire for discount _at_
  http//www.chinamarketresearchreports.com/contacts
  /inquiry.php?name114714 .

7
Investigation Report on China Atorvastatin
Market, 2009-2018

• 8 Prospect of China Atorvastatin Market,
  2014-20188.1 Forecast on Market Size8.2
  Forecast on Competition Pattern
• List of Charts
• Chart Atorvastatin Products Approved to Market in
  China, 2014Chart Forecast on Market Size of
  Hospital-use Atorvastatin in China,
  2014-2018Chart Sales Value of Atorvastatin in
  Global Market, 2009-2013Chart Sales Value of
  Atorvastatin in Hospital Market in China,
  2009-2013Chart Sales Value of Atorvastatin by
  Region in China, 2009-2013Chart Market Share of
  Atorvastatin Enterprises by Sales Value in China,
  2009-2013Chart Hospital Price of Atorvastatin
  Produced by Dalian Pfizer Co., Ltd., 2013Chart
  Hospital Price of Atorvastatin Produced by
  Beijing Jialin Pharmaceutical Co., Ltd. , 2013
• Complete report is available _at_ www.chinamarketrese
  archreports.com/114714-toc.html .